319 related articles for article (PubMed ID: 17598405)
1. In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.
Drenjancević D; Vranes J; Bedenić B; Sakić-Zdravcević K
Coll Antropol; 2007 Mar; 31(1):221-5. PubMed ID: 17598405
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Pruekprasert P; Tunyapanit W
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
[TBL] [Abstract][Full Text] [Related]
3. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
4. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
[TBL] [Abstract][Full Text] [Related]
5. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.
Unal S; Garcia-Rodriguez JA
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):265-71. PubMed ID: 16360550
[TBL] [Abstract][Full Text] [Related]
6. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
Thabaut A; Meyran M
Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428
[TBL] [Abstract][Full Text] [Related]
7. Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.
Sader HS; Castanheira M; Mendes RE; Flamm RK; Farrell DJ; Jones RN
Antimicrob Agents Chemother; 2015; 59(6):3656-9. PubMed ID: 25845861
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.
Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A
J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851
[TBL] [Abstract][Full Text] [Related]
9. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
[TBL] [Abstract][Full Text] [Related]
10. Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.
Henrichfreise B; Wiegand I; Luhmer-Becker I; Wiedemann B
Antimicrob Agents Chemother; 2007 Oct; 51(10):3642-9. PubMed ID: 17682103
[TBL] [Abstract][Full Text] [Related]
11. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
Turner PJ
Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
[TBL] [Abstract][Full Text] [Related]
12. [Pseudomonas aeruginosa: a multicentric study of antibiotic resistance (1999-2000)].
Kalai S; Jouaihia W; Mahjoubi F; Ghozzi R; Thabet L; Ben Rejeb S; Hammami A; Kechrid A; Ben Hassen A
Tunis Med; 2004 Dec; 82(12):1070-4. PubMed ID: 15822507
[TBL] [Abstract][Full Text] [Related]
13. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Apr; 42(4):953-5. PubMed ID: 9559819
[TBL] [Abstract][Full Text] [Related]
14. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
Denis C; Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
[TBL] [Abstract][Full Text] [Related]
15. Effects of imipenem and meropenem on serum sensitivity and surface hydrophobicity of Klebsiella pneumoniae.
Hostacká A
Arzneimittelforschung; 1998 Nov; 48(11):1101-3. PubMed ID: 9850433
[TBL] [Abstract][Full Text] [Related]
16. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
17. Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime.
Bowler LL; Zhanel GG; Ball TB; Saward LL
Antimicrob Agents Chemother; 2012 Sep; 56(9):4976-9. PubMed ID: 22777043
[TBL] [Abstract][Full Text] [Related]
18. MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates.
Turner PJ
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):217-22. PubMed ID: 19070453
[TBL] [Abstract][Full Text] [Related]
19. Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model.
Alou L; Aguilar L; Sevillano D; Giménez MJ; Echeverría O; Gómez-Lus ML; Prieto J
J Antimicrob Chemother; 2005 Feb; 55(2):209-13. PubMed ID: 15650000
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]